These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 37259304)
1. Regulatory Mechanism on Anti-Glycolytic and Anti-Metastatic Activities Induced by Muhammad SNH; Safuwan NAM; Yaacob NS; Fauzi AN Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259304 [TBL] [Abstract][Full Text] [Related]
2. Antiglycolytic Activities of Muhammad SNH; Yaacob NS; Safuwan NAM; Fauzi AN Anticancer Agents Med Chem; 2022; 22(7):1363-1369. PubMed ID: 33906591 [TBL] [Abstract][Full Text] [Related]
3. Strobilanthes crispus bioactive subfraction inhibits tumor progression and improves hematological and morphological parameters in mouse mammary carcinoma model. Baraya YS; Yankuzo HM; Wong KK; Yaacob NS J Ethnopharmacol; 2021 Mar; 267():113522. PubMed ID: 33127562 [TBL] [Abstract][Full Text] [Related]
4. Strobilanthes crispus inhibits migration, invasion and metastasis in breast cancer. Baraya YS; Wong KK; Yaacob NS J Ethnopharmacol; 2019 Apr; 233():13-21. PubMed ID: 30594607 [TBL] [Abstract][Full Text] [Related]
5. Anti-Tumor Action, Clinical Biochemistry Profile and Phytochemical Constituents of a Pharmacologically Active Fraction of S. crispus in NMU-Induced Rat Mammary Tumour Model. Yaacob NS; Yankuzo HM; Devaraj S; Wong JK; Lai CS PLoS One; 2015; 10(5):e0126426. PubMed ID: 26000968 [TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of a bioactive fraction of Strobilanthes crispus in NMU-induced rat mammary tumor model. Yankuzo HM; Baraya YS; Mustapha Z; Wong KK; Yaacob NS J Ethnopharmacol; 2018 Mar; 213():31-37. PubMed ID: 29100935 [TBL] [Abstract][Full Text] [Related]
7. Strobilanthes crispus elicits anti-tumor immunogenicity in in vitro and in vivo metastatic breast carcinoma. Baraya YS; Wee CL; Mustapha Z; Wong KK; Yaacob NS PLoS One; 2022; 17(8):e0271203. PubMed ID: 35972917 [TBL] [Abstract][Full Text] [Related]
8. Synergistic anticancer effects of a bioactive subfraction of Strobilanthes crispus and tamoxifen on MCF-7 and MDA-MB-231 human breast cancer cell lines. Yaacob NS; Kamal NN; Norazmi MN BMC Complement Altern Med; 2014 Jul; 14():252. PubMed ID: 25034326 [TBL] [Abstract][Full Text] [Related]
9. Anticancer activity of a sub-fraction of dichloromethane extract of Strobilanthes crispus on human breast and prostate cancer cells in vitro. Yaacob NS; Hamzah N; Nik Mohamed Kamal NN; Zainal Abidin SA; Lai CS; Navaratnam V; Norazmi MN BMC Complement Altern Med; 2010 Aug; 10():42. PubMed ID: 20684795 [TBL] [Abstract][Full Text] [Related]
10. Exploring the Anticancer Potential of Astragalin in Triple Negative Breast Cancer Cells by Attenuating Glycolytic Pathway through AMPK/mTOR. Zeb A; Khan W; Ul Islam W; Khan F; Khan A; Khan H; Khalid A; Najeeb Ur Rehman ; Ullah A; Al-Harrasi A Curr Med Chem; 2024 Jul; ():. PubMed ID: 39069711 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A. Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639 [TBL] [Abstract][Full Text] [Related]
12. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells. Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171 [TBL] [Abstract][Full Text] [Related]
13. Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer Via Inhibiting PI3K/Akt/mTOR-Mediated Autophagy. Zhang S; Cui T; Duan Y; Zhang H; Wang B; Chen H; Ni J; Shen Y; Xiao-Ai Lv Clin Breast Cancer; 2022 Feb; 22(2):89-97. PubMed ID: 34535390 [TBL] [Abstract][Full Text] [Related]
14. Cell Cycle Modulation of MCF-7 and MDA-MB-231 by a Sub- Fraction of Strobilanthes crispus and its Combination with Tamoxifen. Yaacob NS; Nik Mohamed Kamal NN; Wong KK; Norazmi MN Asian Pac J Cancer Prev; 2015; 16(18):8135-40. PubMed ID: 26745050 [TBL] [Abstract][Full Text] [Related]
15. Sinomenine inhibits hypoxia induced breast cancer side population cells metastasis by PI3K/Akt/mTOR pathway. Song L; Zhang H; Hu M; Liu C; Zhao Y; Zhang S; Liu D Bioorg Med Chem; 2021 Feb; 31():115986. PubMed ID: 33412412 [TBL] [Abstract][Full Text] [Related]
16. 2-Methoxy-1,4-Naphthoquinone (MNQ) Inhibits Glucose Uptake and Lactate Production in Triple-Negative Breast Cancer Cells. Daud SM; Yaacob NS; Fauzi AN Asian Pac J Cancer Prev; 2021 Feb; 22(S1):59-65. PubMed ID: 33576213 [TBL] [Abstract][Full Text] [Related]
17. Effecacy of Biejia (Carapax Trionycis) and Ezhu (Rhizoma Curcumae Phaeocaulis) couplet medicine on epithelial-mesenchymal transition, invasion and migration of MDA-MB-231 triple negative breast cancer cells via PI3K/Akt/mTOR signaling pathway. Zhu MJ; Xie S; Xie Q; Zhu JL; Huang YZ J Tradit Chin Med; 2021 Dec; 41(6):853-861. PubMed ID: 34939381 [TBL] [Abstract][Full Text] [Related]
18. Antimetastatic effect and mechanism of ovatodiolide in MDA-MB-231 human breast cancer cells. Lin KL; Tsai PC; Hsieh CY; Chang LS; Lin SR Chem Biol Interact; 2011 Nov; 194(2-3):148-58. PubMed ID: 22033475 [TBL] [Abstract][Full Text] [Related]
19. A novel and selective inhibitor of PKC ΞΆ potently inhibits human breast cancer metastasis in vitro and in mice. Wu J; Liu S; Fan Z; Zhang L; Tian Y; Yang R Tumour Biol; 2016 Jun; 37(6):8391-401. PubMed ID: 26733166 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of Cytochrome P450s by Strobilanthes crispus Sub-Fraction (F3): Implication for Herb-Drug Interaction. Yong YF; Liew MWO; Yaacob NS Eur J Drug Metab Pharmacokinet; 2022 May; 47(3):431-440. PubMed ID: 35146636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]